| Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard T Poynard, M Munteanu, E Luckina, H Perazzo, Y Ngo, L Royer, ... Journal of hepatology 58 (5), 928-935, 2013 | 201 | 2013 |
| Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data T Poynard, G Lassailly, E Diaz, K Clement, R Caïazzo, J Tordjman, ... PloS one 7 (3), e30325, 2012 | 185 | 2012 |
| COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil R Castro, PM Luz, MD Wakimoto, VG Veloso, B Grinsztejn, H Perazzo Brazilian journal of infectious diseases 24, 180-187, 2020 | 184 | 2020 |
| Gastrointestinal endoscopy during the COVID-19 pandemic: an updated review of guidelines and statements from international and national societies EC Castro Filho, R Castro, FF Fernandes, G Pereira, H Perazzo Gastrointestinal endoscopy 92 (2), 440-445. e6, 2020 | 114 | 2020 |
| Prognostic value of liver fibrosis biomarkers: a meta-analysis T Poynard, Y Ngo, H Perazzo, M Munteanu, P Lebray, J Moussalli, ... Gastroenterology & hepatology 7 (7), 445, 2011 | 107 | 2011 |
| Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference M Munteanu, D Tiniakos, Q Anstee, F Charlotte, G Marchesini, ... Alimentary pharmacology & therapeutics 44 (8), 877-889, 2016 | 99 | 2016 |
| Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono‐infection under long‐term combined antiretroviral therapy H Perazzo, SW Cardoso, C Yanavich, EP Nunes, M Morata, N Gorni, ... Journal of the International AIDS Society 21 (11), e25201, 2018 | 71 | 2018 |
| Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®) T Poynard, J Vergniol, Y Ngo, J Foucher, V Thibault, M Munteanu, ... Journal of Hepatology 61 (5), 994-1003, 2014 | 63 | 2014 |
| Extended use or reuse of N95 respirators during COVID-19 pandemic: an overview of national regulatory authority recommendations LM Kobayashi, BR Marins, PC dos Santos Costa, H Perazzo, R Castro Infection Control & Hospital Epidemiology 41 (11), 1364-1366, 2020 | 59 | 2020 |
| The therapeutic landscape of non‐alcoholic steatohepatitis H Perazzo, JF Dufour Liver international 37 (5), 634-647, 2017 | 51 | 2017 |
| Factors that could impact on liver fibrosis staging by transient elastography H Perazzo, VG Veloso, B Grinsztejn, C Hyde, R Castro International journal of hepatology 2015 (1), 624596, 2015 | 51 | 2015 |
| Prognostic value of liver fibrosis and steatosis biomarkers in type‐2 diabetes and dyslipidaemia H Perazzo, M Munteanu, Y Ngo, P Lebray, N Seurat, F Rutka, M Couteau, ... Alimentary pharmacology & therapeutics 40 (9), 1081-1093, 2014 | 50 | 2014 |
| Points to be considered when using transient elastography for diagnosis of portal hypertension according to the Baveno’s VI consensus H Perazzo, FF Fernandes, EC Castro Filho, RM Perez Journal of Hepatology 63 (4), 1048-1049, 2015 | 44 | 2015 |
| In-hospital mortality and severe outcomes after hospital discharge due to COVID-19: A prospective multicenter study from Brazil H Perazzo, SW Cardoso, MPD Ribeiro, R Moreira, LE Coelho, EM Jalil, ... The Lancet Regional Health–Americas 11, 2022 | 42 | 2022 |
| What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI) H M’Kada, M Munteanu, H Perazzo, Y Ngo, N Ramanujam, ... Regulatory Toxicology and Pharmacology 60 (3), 290-295, 2011 | 41 | 2011 |
| Elevated levels of circulating CDH5 and FABP1 in association with human drug‐induced liver injury M Mikus, K Drobin, M Gry, J Bachmann, J Lindberg, G Yimer, E Aklillu, ... Liver international 37 (1), 132-140, 2017 | 40 | 2017 |
| The interactions of nonalcoholic fatty liver disease and cardiovascular diseases H Perazzo, T Poynard, JF Dufour Clinics in liver disease 18 (1), 233-248, 2014 | 40 | 2014 |
| Real-time shear wave versus transient elastography for predicting fibrosis: applicability, and impact of inflammation and steatosis. A non-invasive comparison T Poynard, T Pham, H Perazzo, M Munteanu, E Luckina, D Elaribi, Y Ngo, ... PloS one 11 (10), e0163276, 2016 | 37 | 2016 |
| Interobserver variability in transient elastography analysis of patients with chronic hepatitis C H Perazzo, FF Fernandes, A Gomes, C Terra, RM Perez, FAF Figueiredo Liver International 35 (5), 1533-1539, 2015 | 37 | 2015 |
| Effectiveness of direct‐acting agents for hepatitis C and liver stiffness changing after sustained virological response FF Fernandes, J Piedade, L Guimaraes, EP Nunes, U Chaves, ... Journal of gastroenterology and hepatology 34 (12), 2187-2195, 2019 | 33 | 2019 |
